Date & Time of Session - 2/24/26 - from 12:00 - 1:00PM
Overview
With the growing utilization of antipsychotics across psychiatric and non-psychiatric indications, the incidence of antipsychotic-induced movement disorders continues to rise. Despite their clinical significance, these disorders are frequently underrecognized or misdiagnosed, contributing to medication non-adherence, psychiatric relapse, functional impairment, and increased hospitalizations. This presentation will highlight the critical role pharmacists play in early identification of risk factors, proactive monitoring, timely treatment implementation, and optimization of therapy to improve patient outcomes.
Objectives
Upon completion of this activity, participants will be able to:
1. Recognize antipsychotic-induced movement disorders (AIMD) and risk factors
2. Evaluate patients with AIMD using validated screening and monitoring tools
3. Apply management strategies for AIMD
Target Audience
Pharmacists, residents, and students
Special Services
If you require special assistance to attend this event, please call Megan Russell at (304) 550-0896.
Speaker:
Whitney Seals, PharmD, MSHA
PGY1 Good Samaritan Hospital Resident
UK College of Pharmacy - Lexington, Kentucky
- 1.00 ACPE
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-0000-25-046-L01-P
- 1.00 ParticipationUK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.

Facebook
X
LinkedIn
Forward